Form D · Other Health Care

InVivoLink, LLC

Nashville, TN · CIK 0001463138

Offering snapshot reported Apr 26, 2010 · SEC filing

Reported sold
$750K
Offering amount: $750K
Investors reported
4
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Apr 12, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 26, 2010Initial$750,000No comparison4SEC filing
Apr 30, 2009Initial$500,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-141109
No sales commissions will be paid.

Source: Form D, filed Apr 26, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adel Elmessiry Executive
Adel El Messiry Executive
Rock Morphis Director
Jim Sohr Director
Ryan Andrew Wells Director, Executive, Promoter

Issuer details

Industry: Other Health Care (See others in industry)

Address:
40 Burton Hills Boulevard Suite 320
Nashville, TN, 37215